Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Appointment of Mr. Richard D'souza as Chief Financial Officer of the company w.e.f. October 16, 2025.
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India Limited has announced the appointment of Mr. Richard D'souza as the new Chief Financial Officer (CFO) of the company, effective October 16, 2025. This is a key managerial personnel (KMP) appointment at the CFO level. No further details about his background, previous role, or whether this is an internal promotion or external hire were provided in the announcement. Shareholders will typically await further disclosures for context on the transition.
A new CFO appointment is a routine corporate governance update. It may signal a leadership transition at the finance function but, without additional details, it is unlikely to have an immediate material impact on the stock price. Investors should watch for any subsequent disclosures regarding the outgoing CFO.